| The
Basics:
Human Insulin, Insulin Analogs,
and Premixed Insulin Analogs
A
Continuing Education Monograph for Pharmacists, Nurses, and
Dietitians
Please
read the following information and select the appropriate link
at the bottom of the page to continue.
Target
Audience: This continuing education (CE) program
is intended for pharmacists, nurses, and dietitians who work
with or anticipate working with patients with diabetes requiring
insulin.
Goal:
To enhance the healthcare professional's knowledge
and understanding of the role of insulin, insulin analog, and
premixed insulin analog products in the treatment of diabetes.
Educational
Objectives: After reading this monograph, the participant
should be able to:
- Describe
the impact of diabetes
- Explain
the relationship between insulin and glucose in the body
- State
the different human insulin products, insulin analogs, and
premixed insulin analogs
- Describe
two different insulin regimens
- Describe
the practical aspects of mixing, storing, and injecting insulin
- Discuss
the prevention and treatment of hypoglycemia
Initial
Release Date: 09/03/2003
Planned Expiration Date: 09/03/2005
To
receive a statement of credit, you must:
- Successfully
complete the post-test (70% or better).
- Complete
the program evaluation.
Your statement
of credit will be issued immediately upon successful completion
of the test and submission of the evaluation form. The statement
of credit specific to your discipline will appear on your screen
and you will be given the option to print it for your files.
No additional statement of credit will be issued.
Editorial
Review Board:
Karmeen
Kulkarni, MS, RD, BC-ADM, CDE
Coordinator, Diabetes Center
St. Mark's Diabetes Center
Salt Lake City, UT
Gayle
Lorenzi, RN, CDE
Community Health Project Manager
University of California, San Diego
La Jolla, CA
Jerry
Meece, RPh, CDE
Owner and Director
Plaza Pharmacy and Wellness Center
Gainesville, TX
Fee:
There is no fee to receive credits for this continuing education
activity.
Commercial
Supporter: This program is supported by an educational
grant from Novo Nordisk Inc.
Trademarks:
NovoLog,
NovoPen, Novolin, Velosulin, Ultralente, Lente, PenFill, FlexPen,
InnoLet and Innovo are registered trademarks of Novo Nordisk
A/S.
InDuo is a registered trademark of LifeScan, Inc.
Humalog and Humulin are registered trademarks of Eli Lilly
and Company.
Lantus is a registered trademark of Aventis Pharmaceuticals,
Inc.
BD Pen is a trademark of Becton Dickinson and Company.
Mix75/25 is a trademark of Eli Lilly and Company.
Faculty
Disclosure Statements: It is the policy of the American
Association of Diabetes Educators and Scherer Clinical Communications
to ensure independence, balance, objectivity, scientific rigor,
and integrity in all of their continuing education activities.
The faculty must disclose to the participants any significant
relationships with the commercial companies whose products or
devices may be mentioned in the activity or with the commercial
supporter of this continuing education activity. The information
is for participant information; it is not assumed that these
relationships will have a negative impact on the content of
the activity. Following are disclosure statements made by the
Editorial Review Board.
Karmeen
Kulkarni, MS, RD, BC-ADM, CDE, has disclosed that she is
a consultant for Eli Lilly and Company and LifeScan Inc., a
Johnson and Johnson company.
Gayle
Lorenzi, RN, CDE, has disclosed that she is a consultant
for Amylin Pharmaceuticals, Inc.
Jerry
Meece, RPh, CDE, has disclosed that he is a consultant for
Eli Lilly and Company and LifeScan, Inc., a Johnson and Johnson
company. He is also on the speaker's bureau for Eli Lilly and
Company, LifeScan, Inc., and Novo Nordisk Inc.
Disclosure
of Unlabeled Use:
This educational
activity may contain discussion of published and/or investigational
uses of agents that are not indicated by the US Food and Drug
Administration (FDA). The American Association of Diabetes Educators,
Scherer Clinical Communications, the commercial supporter, and
the activity's faculty do not endorse the use of any product in
a manner that is not approved by the FDA. Please refer to the
official prescribing information for each product for discussion
of approved indications, contraindications, and warnings.
Disclaimer:
The approval of this educational offering by AADE does not imply
endorsement of specific therapies, treatments, or products discussed
in the presentation. The author, sponsor, and publisher of this
continuing education program have made all reasonable efforts
to ensure that information contained herein is accurate in accordance
with the latest available scientific knowledge at the time of
accreditation of this continuing education program. Information
regarding drugs (e.g., their administration, dosages, contraindications,
adverse reactions, interactions, special warnings, precautions)
and drug delivery systems is subject to change, however, and the
reader is advised to check the manufacturer's package insert for
information concerning recommended dosage and potential problems
or cautions prior to dispensing or administering the drug or using
the drug delivery systems.
Click
the appropriate profession to continue to the activity:
Pharmacists
click here
Nurses
click here
Dietitians
click here
Other
Healthcare Professionals click here
Copyright©
2003 Scherer Clinical Communications. All rights reserved.
|
